Transcription of POST-SPLENECTOMY VACCINE PROPHYLAXIS
{{id}} {{{paragraph}}}
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care practices based upon the available medical literature and clinical expertise at the time of development. They should not be considered to be accepted protocol or policy, nor are intended to replace clinical judgment or dictate care of individual patients. EVIDENCE DEFINITIONS Class I: Prospective randomized controlled trial. Class II: Prospective clinical study or retrospective analysis of reliable data. Includes observational, cohort, prevalence, or case control studies.
3 Approved 1/7/03 Revised 10/17/06, 11/1/11, 7/29/15 All of the vaccines can cause adverse reactions which are generally self-limiting and resolve 24-72 hours
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
For Adults, VACCINES, Information Series for Adults, Vaccinations for adults, Adults, Pertussis vaccines for Australians - NCIRS fact, Pertussis vaccines for Australians | NCIRS Fact, INFORMATION, Zoster Vaccine, Immunization schedule for adults, POST-SPLENECTOMY VACCINE PROPHYLAXIS, SAGE pertussis working group Background paper